Osteogenic molecules for clinical applications: improving the BMP-collagen system

Area of Science:

• Orthopaedic surgery
• Tissue engineering
• Biomaterials science

Background:

• Bone morphogenetic proteins (BMPs), particularly BMP-2 and BMP-7, are key osteogenic growth factors for bone regeneration.
• Current clinical applications utilize BMPs with collagen type I carriers, but high doses raise cost and long-term safety concerns due to pleiotropy and ectopic ossification risks.

Purpose of the Study:

• To review strategies for enhancing the efficiency, biosecurity, and cost-effectiveness of BMP-based bone regeneration therapies.
• To summarize promising research, including novel recombinant BMP development and combination therapies.

Main Methods:

• Review of existing literature on BMP applications in orthopaedics and tissue engineering.
• Focus on two primary approaches: developing modified recombinant BMPs and combining BMPs with other therapeutic molecules.

Main Results:

• Identified limitations of current BMP-collagen systems, including high costs and uncertain long-term safety.
• Highlighted two promising avenues: engineering enhanced BMPs and developing synergistic combinations with other growth factors or molecules.

Conclusions:

• Improvements in BMP-collagen systems are necessary for more efficient, safer, and cost-effective bone regeneration.
• Developing advanced recombinant BMPs and complementary molecular strategies holds significant potential for future orthopaedic applications.